Cinitapride tartrate
CAS: 96623-56-2
Ref. 3D-FC146198
| 1mg | A consultar | ||
| 2mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar |
Informação sobre produto
Cinitapride is a prokinetic drug that is used to treat symptoms of gastroesophageal reflux disease and Parkinson's disease. It increases the speed with which food moves through the digestive tract by increasing the muscle contractions in the stomach, thereby decreasing the amount of time it takes for food to move through the intestines. Cinitapride also has been shown to increase levels of PGE2 in humans. In addition, cinitapride is a potent inhibitor of 5-HT2 receptors. The therapeutic effect of cinitapride may be due to its ability to inhibit hydrogen tartrate (HAT) production by recombinant cytochrome P450 enzymes. This inhibition leads to decreased levels of HAT substrate, which decreases HAT activity and inhibits platelet aggregation. Cinitapride also inhibits metoprolol succinate from binding with dinucleotide phosphate (DNP), resulting in an increased rate of reaction between DNP and oxygen molecules, leading to
Propriedades químicas
Consulta técnica sobre: 3D-FC146198 Cinitapride tartrate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
